David A. Siegel Senseonics Holdings, Inc. Transaction History

Two Sigma Advisers, LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.54 - $3.71 $500,500 - $1.21 Million	-325,000 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.58 - $3.91 $477,558 - $723,741	-185,100 Reduced 36.29%	325,000 $868,000
Q3 2021 Nov 15, 2021	BUY	$2.77 - $4.05 $842,911 - $1.23 Million	304,300 Added 147.86%	510,100 $1.73 Million
Q2 2021 Aug 16, 2021	BUY	$1.71 - $4.14 $7,695 - $18,630	4,500 Added 2.24%	205,800 $790,000
Q1 2021 May 17, 2021	BUY	$0.85 - $5.27 $171,105 - $1.06 Million	201,300 New	201,300 $531,000

Q3 2018 Nov 14, 2018	SELL	$3.4 - $4.84 $178,200 - $253,674	-52,412 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$3.03 - $4.98 $158,808 - $261,011	52,412 New	52,412 $215,000

148

66.3M

392K

207K

Ticker SENS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 465,447,008
Market Cap $186M
Description
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.